Use of Continuous Glucose Monitoring in the Detection and Prevention of Hypoglycemia

Thompson CJ Cummings JF Chalmers J Gould C Newton RW : How have patients reacted to the implications of the DCCT? Diabetes Care 1996; 19: 876–879.

Zammitt NN Frier BM : Hypoglycemia in Type 2 diabetes: Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28: 2948–61.

Fanelli CG Epifano L Rambotti AM Pampanelli S Di Vincenzo A Modarelli F Lepore M Annibale B Ciofetta M Bottini P , and: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993; 42: 1683–1689.

Garg S Zisser H Schwartz S Bailey T Kaplan R Ellis S Jovanovic L : Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor: A randomized controlled trial. Diabetes Care 2006; 29: 44–50.

Clarke WL Anderson S Farhy L Breton M Gonder-Frederick L Cox D Kovatchev B : Evaluating the Clinical Accuracy of Two Continuous Glucose Sensors Using Continuous Glucose-Error Grid Analysis. Diabetes Care 2005; 28: 2412–2417.

Evans ML Pernet A Lomas J Jones J Amiel SA : Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care 2000; 23: 893–897.

Cheyne EH Cavan DA Kerr D : Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers. Diabetes Technol Ther 2002; 4: 607–613.

Nielsen JK Djurhuus CB Gravholt CH Carus AC Granild-Jensen J Ørskov H Christiansen JS : Continuous Glucose Monitoring in Interstitial Subcutaneous Adipose Tissue and Skeletal Muscle Reflects Excursions in Cerebral Cortex. Diabetes 2005; 54: 1635–1639.